| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.0097 | 1 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |